Form 4 Filing for Michael A. Panzara

Michael A. Panzara, Chief Medical Officer of IMMUNIC, INC., was granted 300,000 stock options on April 24, 2026. These options have an exercise price of $8.80 and an expiration date of April 24, 2036. The options are subject to time-based vesting: 50% vest on April 24, 2027, and the remaining 50% vest in 24 equal monthly installments thereafter, contingent upon continued employment. Following this transaction, Mr. Panzara holds 300,000 shares underlying these options. The filing is a Form 4, indicating a transaction by an insider.